Загрузка страницы
Все видеоНовые видеоПопулярные видеоКатегории видео

Myokardia CEO talk about its new trial data to treat heart disease

Myokardia develops therapies and treatments for inherited heart conditions, particularly hypertrophic cardiomyopathy or HCM, which affects 650,000 people in the U.S. Myokardia CEO Tassos Gianakakos joins ‘Closing Bell’ to discuss its treatments.

Видео Myokardia CEO talk about its new trial data to treat heart disease канала CNBC Television
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
1 сентября 2020 г. 2:12:43
00:04:37
CNBC Television
Теги
Правообладателям
Жалоба
Комментарии
Другие видео канала
A New Genetic Therapy for Cardiomyopathy?A New Genetic Therapy for Cardiomyopathy?Mavacamten: a dawn to hypertrophic cardiomyopathMavacamten: a dawn to hypertrophic cardiomyopathBristol-Myers Squibb CEO on the drug pipeline, 2020 outlook and moreBristol-Myers Squibb CEO on the drug pipeline, 2020 outlook and moreACC: Mavacamten For Hypertrophic CardiomyopathyACC: Mavacamten For Hypertrophic CardiomyopathyObstructive Hypertrophic Cardiomyopathy: Ben’s HCM Patient StoryObstructive Hypertrophic Cardiomyopathy: Ben’s HCM Patient StoryBristol-Myers Squibb Large-Scale Cell Culture Biologics Manufacturing Facility Project OverviewBristol-Myers Squibb Large-Scale Cell Culture Biologics Manufacturing Facility Project OverviewMandy's Story of LIVING with HCMMandy's Story of LIVING with HCMLets talk about health (Nutrition)Lets talk about health (Nutrition)Bristol-Myers Squibb CEO on $13 billion MyoKardia acquisition: 'potentially revolutionary medicine'Bristol-Myers Squibb CEO on $13 billion MyoKardia acquisition: 'potentially revolutionary medicine'ESC TV at ESC Congress 2020 - EXPLORER-HCM (Investigator)ESC TV at ESC Congress 2020 - EXPLORER-HCM (Investigator)Bristol-Myers upgraded to Buy at GuggenheimBristol-Myers upgraded to Buy at GuggenheimStents: Answers to Common QuestionsStents: Answers to Common QuestionsHypertrophic Cardiomyopathy: The Future is Now (Ahmad Masri, MD) October 22, 2020Hypertrophic Cardiomyopathy: The Future is Now (Ahmad Masri, MD) October 22, 2020Why this analyst has an outperform rating on Plug PowerWhy this analyst has an outperform rating on Plug PowerHypertrophic Cardiomyopathy (HCM) Mechanism of Disease VideoHypertrophic Cardiomyopathy (HCM) Mechanism of Disease VideoTypes of Heart Failure – Cardiology | LecturioTypes of Heart Failure – Cardiology | LecturioInvestors shouldn't expect to make any money in Didi's IPO: ExpertInvestors shouldn't expect to make any money in Didi's IPO: ExpertHypertrophic cardiomyopathy: Pathophysiology and diagnosis | NCLEX-RN | Khan AcademyHypertrophic cardiomyopathy: Pathophysiology and diagnosis | NCLEX-RN | Khan AcademyCardiomyopathy: latest news on genetics and treatmentsCardiomyopathy: latest news on genetics and treatmentsStill optimistic about second half of 2021: Wilmington's Meghan ShueStill optimistic about second half of 2021: Wilmington's Meghan Shue
Статистика портала
Яндекс.Метрика
© 2008-2024 «Информационно-развлекательный портал города Верхняя Салда»
| Карта портала | Реклама | Контакты | Сообщить об ошибке | Соглашения
salda.ws salda.ws@mail.ru
Сейчас на сайте: 512 Статистика портала